GLP-1 Weight Loss Telehealth in New Hampshire

New Hampshire is home to roughly 1.4 million people, and about 31.0% of New Hampshireadults have obesity. Whether treatment is appropriate for any individual is a licensed physician's decision; access should not depend on long waits or expensive in-person visits.

Cities like Manchester, Nashua, Concord have great healthcare networks, but obesity-medicine specialists often have months-long waitlists. Telehealth bridges that gap. From your home anywhere in New Hampshire, you can complete a medical assessment and be reviewed by a NH-licensed physician, without an office visit, once we open.

New Hampshire telehealth rules: New Hampshire allows licensed physicians to prescribe non-controlled medications via telehealth, including compounded GLP-1 medications dispensed by state-licensed pharmacies.

New Hampshire keeps its telehealth law in two places, and reading them together tells you almost everything about how a remote visit works here. RSA 310:7, housed in the chapter governing the Office of Professional Licensure and Certification, sets the rules for every licensed health profession at once. RSA 329:1-d, inside the physicians' chapter, repeats and sharpens those rules for doctors specifically. Both were amended as recently as 2025, so this is a statute the legislature actively maintains, not a relic. The licensing rule is stated plainly. Under RSA 310:7, III, an out-of-state health care professional providing services by telemedicine or telehealth "shall be required to be licensed, certified, or registered by the appropriate New Hampshire licensing body, or pursuant to a licensing compact or endorsement, if the patient is physically located in New Hampshire at the time of service." Note the two details packed into that sentence. First, what matters is where the patient is at the moment of the visit, not where the doctor sits. Second, New Hampshire expressly accepts licensure "pursuant to a licensing compact," which matters because physicians can qualify through the Interstate Medical Licensure Compact, which New Hampshire has enacted as RSA chapter 329-C, rather than only through a standalone New Hampshire license. The physicians' chapter says the same thing in its own words: RSA 329:1-d, II provides that an out-of-state physician practicing telemedicine "shall be deemed to be in the practice of medicine" and must be licensed under the chapter. The carve-outs are narrow. Both sections exempt an out-of-state physician called in consultation under RSA 329:21, II by a New Hampshire-licensed clinician who bears responsibility for the patient's diagnosis and treatment, and the statute warns that regular or frequent consultation of that kind becomes unlicensed practice. RSA 310:7 carries its own qualifiers as well: paragraph III opens with "unless otherwise prescribed by statute," it sets separate licensing rules for patients in the custody of the department of corrections, and paragraph VI lets a listed set of out-of-state providers give consultation services or follow-up care by telehealth to a patient they previously treated in the state where they are licensed. On how a visit may happen, New Hampshire is deliberately broad. Both sections define telemedicine as the use of "audio, video, or other electronic media and technologies" for diagnosis, consultation, or treatment, "including the use of synchronous or asynchronous interactions." RSA 310:7, I then defines those terms: a synchronous interaction "occurs in real time," an asynchronous one "does not occur in real time." So a live video visit, a phone call, and a structured message exchange reviewed by a clinician later can all be telemedicine under this statute. What New Hampshire does not do is impose a general requirement of an in-person examination before care can begin remotely. Instead, RSA 310:7, IV and RSA 329:1-d, V put the weight on the standard of care: a provider treating you by telemedicine must "use the same standard of care as used in an in-person encounter," must maintain a medical record, and, with your consent, must forward that record to your primary care or treating provider if appropriate. The prescribing rules follow the same pattern. RSA 329:1-d, III addresses controlled drugs directly: a New Hampshire-licensed physician may prescribe controlled drugs in schedules II through IV by telemedicine, but a follow-up evaluation must then happen "at intervals appropriate for the patient, medical condition, and drug, but not less than annually." For medications that are not controlled substances, the statute attaches no special telemedicine condition at all; ordinary prescribing law and the in-person standard of care govern. One detail shows how precisely this legislature writes: the only questionnaire prohibition in the telemedicine section itself sits in RSA 329:1-d, VI, which says a physician may not determine an ophthalmic prescription "solely by use of an online questionnaire," a rule that applies to eyeglass and contact lens prescriptions. The legislature knew how to ban questionnaire-only prescribing and chose to do it there for one narrow category, which is a useful reminder that elsewhere in the telemedicine rules the governing test is the same standard of care a doctor owes you in an exam room. For a patient in New Hampshire, the practical summary is this: your telehealth clinician must hold New Hampshire licensure or compact-based authorization, your visit can lawfully be live or asynchronous, your clinician owes you exactly the care an office visit would, and a written record of the encounter must exist and can follow you to your regular doctor. That is the framework Majesta is building against as we prepare to serve New Hampshire.

You can verify any physician's New Hampshire license at the New Hampshire Board of Medicine.